Center for Experimental and Molecular Medicine, Amsterdam UMC location University of Amsterdam, Amsterdam, The Netherlands
Department of Intensive Care Medicine, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.
Thorax. 2024 Oct 16;79(11):1086-1090. doi: 10.1136/thorax-2024-222026.
Mesenchymal stem cells (MSC) have immune regulatory properties that may ameliorate pathophysiological processes in sepsis. We determined the effect of allogeneic adipose-derived MSCs (Cx611) on the host response during sepsis due to community-acquired bacterial pneumonia (CABP) by measuring 29 plasma biomarkers and blood transcriptomes at six time points in 82 patients randomised to two intravenous infusions of Cx611 or placebo. Cx611 treatment enhanced several endothelial cell and procoagulant response plasma biomarkers, and led to increased expression of pathways related to innate immunity, haemostasis and apoptosis. Cx611 infusion in sepsis due to CABP is associated with broad host response alterations.
间充质干细胞(MSC)具有免疫调节特性,可能改善脓毒症的病理生理过程。我们通过在 82 名随机分为接受两次静脉注射 Cx611 或安慰剂的患者的六个时间点测量 29 种血浆生物标志物和血液转录组,来确定同种异体脂肪来源的 MSC(Cx611)对社区获得性细菌性肺炎(CABP)引起的脓毒症宿主反应的影响。Cx611 治疗增强了几种内皮细胞和促凝反应的血浆生物标志物,并导致与先天免疫、止血和细胞凋亡相关的途径表达增加。CABP 引起的脓毒症中 Cx611 的输注与宿主反应的广泛改变有关。